InsidersTradesSigma
Follow the MaxCyte Inc. stock price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares are quoted on the UK market, under the supervision of RNS (LSE). The latest transaction was filed on 31 January 2024 (Exercise). Among the most active insiders: John Johnston. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
MaxCyte Inc. 是一家专注于基因和细胞转移技术的公司。它为研究和细胞疗法开发解决方案。